Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Appli... ( TARRYTOWN N.Y. Oct. 24 /- Emisphe...)

Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology

Date:10/24/2007

TARRYTOWN, N.Y., Oct. 24 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that Gary Riley has been appointed to the position of Vice President, Nonclinical Development and Applied Biology, effective November 6, 2007. Dr. Riley will be responsible for the oversight and management of nonclinical drug efficacy and safety programs, including regulatory toxicology, and the strategic design of discovery projects. Dr. Riley will report directly to Michael V. Novinski, President and Chief Executive Officer. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology.

"Gary Riley has great hands-on experience in managing all aspects of nonclinical drug development and in bringing issues before the FDA and European Regulatory Agencies," said Michael V. Novinski, President and Chief Executive Officer of Emisphere Technologies, Inc. "Dr. Riley also brings a real expertise in integrating knowledge of the biological response to novel drug delivery technologies and accelerating the product cycle. It is a wealth of experience that we are excited to bring to Emisphere."

Dr. Riley has over 18 years experience as a nonclinical scientist and manager in the biotechnology and pharmaceutical industries. He was the Vice President of Toxicology and Applied Biology at Alkermes, Inc. in Cambridge, Massachusetts, where he directed the design, execution and interpretation of toxicology and nonclinical efficacy programs for a wide range of parenteral drug delivery formulations. Dr. Riley played a key role in obtaining FDA approvals for three novel controlled release for
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President

Post Your Comments:

(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...

(Date:5/21/2013)... Many have long discussed the link ... Recently physicians from Clinical Psychiatry.com readdressed the ... skin, and suggested using hypnotherapy and other ... from stress that cause acne. , Doctors in the ... brings about, stress causes changes in the skin that ...

(Date:5/21/2013)... , May 21, 2013 Personal Genome Diagnostics ... its proprietary methodologies and expertise in genomic analysis ... targets in collaboration with Blueprint Medicines. PGDx is ... identifying genomic alterations in tumors, and Blueprint Medicines ... inhibitors for a genetically defined patient population. ...

(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...

Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3 Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2

[0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions [0] Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets [0] Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.

... , EMERYVILLE, Calif. , Feb. 1 ... has appointed Ted W. Love , M.D., Executive Vice President ... , M.D., Ph.D., who has served as Interim Chief Medical Officer ... reporting to Dr. Love. , In his new role, Dr. ...

... ... impact of Prevagen® on cognitive function. Men and women aged 40 years and older who ... Madison Memory Study . , ... February 1, 2010 -- Quincy Bioscience is seeking men and women 40 years and older who ...

... ... , ... 29, 2010 -- Leaders from DuPont Danisco Cellulosic Ethanol (DDCE), University of ... first cellulosic ethanol demonstration facilities, located in Vonore, Tenn. The 74,000-square-foot plant has started ...

Cached Biology Technology:Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 2 Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 3 Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 4 Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 5 Memory Study Enrolling Participants Evaluating Memory Loss Vitamin 2 First Facility to Efficiently Convert Corncobs and Bioenergy Crops to Cellulosic Ethanol Opens 2 First Facility to Efficiently Convert Corncobs and Bioenergy Crops to Cellulosic Ethanol Opens 3 First Facility to Efficiently Convert Corncobs and Bioenergy Crops to Cellulosic Ethanol Opens 4

Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development Memory Study Enrolling Participants Evaluating Memory Loss Vitamin First Facility to Efficiently Convert Corncobs and Bioenergy Crops to Cellulosic Ethanol Opens

(Date:5/20/2013)... New research suggests that a compound abundant in ... escape death. , By altering a very specific ... cells into normal cells that die as scheduled. , ... a process that would cause them to die on ... This study in cells, led by Ohio State University ...

(Date:5/20/2013)... Geology articles posted online ahead of ... wide swath of geoscience subdisciplines, including minerals exploration, ... Locations studied include Siberia; the Sumatran subduction margin; ... Ukraine; Mars; and the Southeastern U.S. Atlantic Margin. ... and plate tectonics;, 2. The clear fingerprint of ...

(Date:5/18/2013)... The AGA Research Foundation is honored to announce ... in Digestive Cancer, which will support Andrew D. Rhim, ... University of Pennsylvania, Philadelphia, as he furthers his research ... and cancer progression. , "The AGA Research Foundation is ... distinguished clinicians and AGA Legacy Society members," said Nicholas ...

[0] The compound in the Mediterranean diet that makes cancer cells 'mortal'[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] AGA Research Foundation grant furthers digestive cancer research

... -- Dr. Dariusz Malinowski is seeing blue, and he is ... Malinowski, an AgriLife Research plant physiologist and forage agronomist in ... Texas Foundation Seed and Dr. William Pinchak and Shane Martin ... The project was first a private ...

... -- with its ubiquitous electronic devices and electrical power ... less than two centuries ago, of the link between ... forces on a global scale, physicists still struggle to ... Two theoretical physicists from Rice University are reporting ...

... Arizona-led consortium has been awarded $9.9 million from the ... the wild relatives of cultivated rice with the ultimate ... of withstanding drought and poorer soils and produce higher ... main goals are to study the genes of different ...

Cached Biology News:AgriLife research hibiscus breeder comes up with the blue 2 AgriLife research hibiscus breeder comes up with the blue 3 Magnetism's subatomic roots 2 Magnetism's subatomic roots 3 University of Arizona-led group awarded $9.9 million to develop 'super rice' 2 University of Arizona-led group awarded $9.9 million to develop 'super rice' 3 University of Arizona-led group awarded $9.9 million to develop 'super rice' 4

AgriLife research hibiscus breeder comes up with the blue Magnetism's subatomic roots University of Arizona-led group awarded $9.9 million to develop 'super rice'

Extracti-Gel D Detergent Removing Gel...

Physical Form: saline suspension with ethanol Particle Dim: mean particle size 50 μm Matrix: HyperD F. Useful for the removal of detergents from protein samples....

SDS-OutT SDS Precipitation Reagent...

... Workstation from Caliper represents a revolutionary breakthrough ... first time the ability to generate real-time ... changing conditions. In addition, each channel ... to changes in temperature, and offers its ...

Biology Products:

EXTRACTI-GEL D from Pierce Biotechnology, Inc.Solvent-Detergent Removal Resin from Sigma-Aldrich SDSOUT SDS PRECIPITATION from Pierce Biotechnology, Inc.Caliper Sciclone inL10 Workstation from Caliper Life Sciences